Onkologie. 2010:4(5):293-296

Histopathological diagnosis of soft tissue tumours

Karel Veselý
I. patologicko-anatomický ústav LF MU a FN u sv. Anny v Brně

An introduction to a classification and tissue diagnostics of soft tissue tumors is presented. The review is focused on tissue retrieval

methods for histopathological and other ancillary studies, which are essential for histotyping and grading of soft tissue sarcomas and

thus for planning further therapy. The growing importance of the molecular biologic techniques, which enables a detection of specific

translocations characteristic for some soft tissue neoplasms, is highlighted. The benefits and shortcomings of the currently employed

grading systems are briefly summarized and potential future trends are delineated.

Keywords: soft tissue neoplasms, sarcoma, grade

Published: December 31, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Veselý K. Histopathological diagnosis of soft tissue tumours. Onkologie. 2010;4(5):293-296.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Nijhuis PH, Schaapveld M, Otter R, et al. Epidemiological aspects of soft tissue sarcomas (STS) - consequences for the design of clinical STS trials. Eur J Cancer. 1999; 35: 1705-1710. Go to original source... Go to PubMed...
    2. Heim-Hall J, Yohe SL. Application of immunohistochemistry to soft tissue neoplasms. Arch Pathol Lab Med. 2008; 132(3): 476-489. Go to original source...
    3. Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. World Health Organization Classification of Tumours; vol 5. Lyon, France: IARC Press; 2002.
    4. Cormier JN, Pollock RE. Soft tissue sarcomas. CA Cancer J Clin. 2004; 54: 94-109. Go to original source... Go to PubMed...
    5. Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology. 2006; 48: 3-12. Go to original source... Go to PubMed...
    6. Oda Y, Tamiya S, Oshiro Y, et al. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Pathol Int. 2002; 52: 595-606. Go to original source... Go to PubMed...
    7. Clark MA, Fisher C, Judson I, et al. Soft-tissue sarcomas in adults. N Engl J Med. 2005; 353: 701-711. Go to original source... Go to PubMed...
    8. Skrzynski MC, Biermann JS, Montag A, Simon MA. Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors. J Bone Joint Surg Am. 1996; 78(5): 644-649. Go to original source... Go to PubMed...
    9. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996; 78(5): 656-663. Go to original source... Go to PubMed...
    10. Brown FM, Fletcher CD. Problems in grading soft tissue sarcomas. Am J Clin Pathol. 2000; 114(Suppl): S82-89. Go to original source... Go to PubMed...
    11. Palmer HE, Mukunyadzi P, Culbreth W, et al. Subgrouping and grading of soft-tissue sarcomas by fine-needle aspiration cytology: a histopathologic correlation study. Diagn Cytopathol. 2001; 24: 307-316. Go to original source... Go to PubMed...
    12. Alveg?rd TA, Berg NO. Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol. 1989; 7: 1845-1851. Go to original source... Go to PubMed...
    13. Arbiser ZK, Folpe AL, Weiss SW. Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol. 2001; 116: 473-476. Go to original source... Go to PubMed...
    14. Fisher C. The value of electronmicroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: a study of 200 cases. Histopathology. 1990; 16(5): 441-454. Go to original source... Go to PubMed...
    15. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYTSSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002; 62: 135-140.
    16. Segal NH, Pavlidis P, Antonescu CR, et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol. 2003; 163: 691-700. Go to original source... Go to PubMed...
    17. Borden EC, Baker LH, Bell RS, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003; 9: 1941-1956.
    18. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001; 91: 1914-1926. Go to original source...
    19. Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults: study of pathological prognostic variables and definition of histopathological grading system. Int J Cancer. 1984; 33: 37-42. Go to original source... Go to PubMed...
    20. Costa J, Wesley RA, Glatstein E, et al. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer. 1984; 53: 530-541. Go to original source...
    21. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001; 91: 1914-1926. Go to original source...
    22. Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med. 2006; 130: 1448-1453. Go to original source...
    23. Hashimoto H, Daimaru Y, Takeshita S, et al. Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer. 1992; 70: 2816-2822. Go to original source...
    24. Lin CN, Chou SC, Li CF, et al. Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival. J Surg Oncol. 2006; 93: 294-303. Go to original source... Go to PubMed...
    25. Graadt Van Roggen JF. The histopathological grading of soft tissue tumours: current concepts. Current Diagnostic Pathology. 2001; 7: 1-7. Go to original source...
    26. Hasegawa T. Histological grading and MIB-1 labeling index of soft-tissue sarcomas. Pathol Int. 2007; 57: 121-125. Go to original source... Go to PubMed...
    27. Plaat BE, Muntinghe FL, Molenaar WM, et al. Clinical outcome of patients with previously untreated soft tissue sarcomas in relation to tumor grade, DNA ploidy and karyotype. Int J Cancer. 1997; 74: 396-402. Go to original source... Go to PubMed...
    28. Schneider-Stock R, Ziegeler A, Haeckel C, et al. Prognostic relevance of p53 alterations and Mib-1 proliferation index in subgroups of primary liposarcomas. Clin Cancer Res. 1999; 5: 2830-2835.
    29. Kawai A, Woodruff J, Healey JH, et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998; 338: 153-160. Go to original source... Go to PubMed...
    30. Guillou L, Benhattar J, Bonichon F, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004; 22: 4040-4050. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.